DIA:CONN P8 Smart Insulin Pen with CGM-Based Coaching

DIA:CONN P8 Smart Insulin Pen · G2e Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DIA:CONN P8 Smart Insulin Pen with CGM-Based Coaching, covering 2025-06-04 to 2025-06-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DIA:CONN P8 Smart Insulin Pen With CGM-Based Coaching in Patients With Type 1 or Type 2 Diabetes [NA]

See pricing